BioPh Japan The Japanese pharmaceutical manufacturers have been eager to catch up the US and European players in the bio field by investing and cooperating with bio ventures & universities. The government has also been investing in infrastructure development such as bio industrial cluster projects and setting up support programs for bio ventures & universities in order to enhance Japan’s bio pharma industry. Biotechnology-based drugs are anticipated to be one of the key drivers of the pharmaceutical market and this is reflected in the growing number biotechnology based drugs among newly approved medicines. BioPh brings bio Solutions to CPhI Japan and is for companies and organisations involved in the research and development of new treatment methods arising from biotechnical processes or which are derived from, or use live organisms. If you are a supplier of bio pharma raw materials, services or equipment, don’t miss this opportunity to enjoy enhanced visibility by exhibiting in this hot-topic pavilion. | 
|
Exhibitor Profile
Academia and Research Centres Analytical Chemistry Analytical Methods Bio Clusters Bioelectronics Bioinformatics Biopharmaceutical and Bio process Technologies Biotechnology and related specialities Cell biology Country / Regional pavilions Diagnostics: Antibodies Molecular Biology Equipment and supplies Genomics & Proteomics | Immunology Investment Companies Medicinal chemistry Patent and legal services Platform technologies: • Functional genomics • Proteomics • Combinatorial Chemistry • High throughput screening Process validation Protein chemistry Technology and software Therapeutics Toxicology / virology |
Interested?
Join these exhibitors and many more in networking with our international visitors and benefit from the thriving pharmaceutical market and opportunity this unique business platform and the co-located events offer. For more information on how to exhibit at BioPh Japan please contact Mr. Martin Wilson at +31 (0) 20 40 99 505 or send an email to martin.wilson@ubm.com.